UBS Group’s Novanta NOVT Stock Holding History

UBS Group’s Portfolio NOVT Stock Details NOVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.03M	Buy	+31,000	New	+$4.48M	﹤0.01%	4155

Other funds holding NOVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

UBS Group's NOVT Position: Q2 2026 in Review

UBS Group increased its Novanta (NOVT) stake by 320% in Q2 2026, buying an estimated $24.5M and bringing the position to 222,416 shares worth $36.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

UBS Group first reported a position in NOVT in Q2 2016 and has held it in 40 quarters since. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

UBS Group held 222,416 shares of Novanta worth $36.1M as of Q2 2026.
UBS Group bought 169,437 Novanta shares in Q2 2026, an estimated $24.5M.
Novanta made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2079 holding.
UBS Group first reported a position in Novanta in Q2 2016 and has held it in 40 quarters since.
389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.